Published in J Virol on December 01, 1973
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52
Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J Cell Biol (1981) 7.07
Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol (1981) 6.46
Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins. Proc Natl Acad Sci U S A (1977) 5.87
Microbial surfaces in relation to pathogenicity. Bacteriol Rev (1977) 5.79
pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc Natl Acad Sci U S A (1980) 5.21
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol (1987) 3.65
Fusion of Semliki forest virus with the plasma membrane can be induced by low pH. J Cell Biol (1980) 3.47
Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci U S A (1978) 3.42
Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proc Natl Acad Sci U S A (1984) 3.42
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med (1980) 3.32
Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol (1992) 3.20
Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J Clin Microbiol (1979) 3.05
Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol (1996) 2.63
Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A (1985) 2.56
Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J Virol (1999) 2.51
Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol (1992) 2.47
Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. Proc Natl Acad Sci U S A (1981) 2.31
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene. J Virol (1990) 2.17
Correct proteolytic cleavage is required for the cell adhesive function of uvomorulin. J Cell Biol (1990) 2.14
Cell surface expression of fusogenic vesicular stomatitis virus G protein from cloned cDNA. EMBO J (1984) 2.10
The role of envelope glycoprotein processing in murine leukemia virus infection. J Virol (1987) 2.06
Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J Virol (1992) 1.91
Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J Virol (1991) 1.91
Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion. J Virol (1992) 1.76
Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J Virol (1997) 1.71
Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide. J Virol (1989) 1.68
Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity. J Virol (1987) 1.67
Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus. J Virol (1988) 1.67
An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J (1990) 1.66
Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol (2006) 1.61
The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J Virol (1988) 1.60
Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity. J Virol (1993) 1.56
Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J (1992) 1.54
Glycoproteins of measles virus under reducing and nonreducing conditions. J Virol (1978) 1.51
Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. J Virol (1988) 1.49
Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest (2005) 1.42
Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs. Infect Immun (1983) 1.39
Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activation. Infect Immun (1978) 1.32
Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein. Proc Natl Acad Sci U S A (2012) 1.30
Analysis of Sendai virus mRNAs with cDNA clones of viral genes and sequences of biologically important regions of the fusion protein. Proc Natl Acad Sci U S A (1984) 1.30
Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation. J Virol (1997) 1.26
Glycoproteins of Sendai virus are transmembrane proteins. Proc Natl Acad Sci U S A (1979) 1.22
Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2. J Virol (1993) 1.22
Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3' proximal 1013 nucleotides of the F gene. Nucleic Acids Res (1984) 1.16
Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium. J Virol (1990) 1.14
Failure to cleave measles virus fusion protein in lymphoid cells. J Exp Med (1981) 1.13
Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity. J Virol (1992) 1.12
Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J Virol (1990) 1.11
Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites. J Virol (1990) 1.09
Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses. J Mol Genet Med (2008) 1.07
Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein. J Virol (1989) 1.06
Physical and chemical methods for enhancing rapid detection of viruses and other agents. Clin Microbiol Rev (1993) 1.05
Mutation in the matrix protein of Newcastle disease virus can result in decreased fusion glycoprotein incorporation into particles and decreased infectivity. J Virol (1984) 1.04
Isolation and characterization of macrophage phagosomes containing infectious and heat-inactivated Chlamydia psittaci: two phagosomes with different intracellular behaviors. Infect Immun (1983) 1.03
Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children. J Virol (1984) 1.02
Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. J Virol (1985) 1.02
Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein. J Virol (1987) 1.01
Enhancement of membrane-fusing activity of sendai virus by exposure of the virus to basic pH is correlated with a conformational change in the fusion protein. Proc Natl Acad Sci U S A (1982) 0.99
Conversion of a class II integral membrane protein into a soluble and efficiently secreted protein: multiple intracellular and extracellular oligomeric and conformational forms. J Cell Biol (1990) 0.99
Role of heterologous and homologous glycoproteins in phenotypic mixing between Sendai virus and vesicular stomatitis virus. J Virol (1989) 0.98
Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus. J Virol (1996) 0.98
Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine. Curr Gene Ther (2012) 0.97
Transmembrane phospholipid motions induced by F glycoprotein in hemagglutinating virus of Japan. J Virol (1977) 0.96
Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery. J Biol Chem (2011) 0.96
Assignment of disulfide bridges in the fusion glycoprotein of Sendai virus. J Virol (1994) 0.96
Sendai virus efficiently infects cells via the asialoglycoprotein receptor and requires the presence of cleaved F0 precursor proteins for this alternative route of cell entry. J Virol (1997) 0.95
Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry. Virology (2015) 0.94
Trypsin action on the growth of Sendai virus in tissue culture cells. IV. Evidence for activation of sendai virus by cleavage of a glycoprotein. J Virol (1976) 0.94
Experimental parainfluenzavirus infection in mice: fatal illness with atrophy of thymus and spleen in mice caused by a variant of parainfluenza 3 virus. Infect Immun (1982) 0.94
Nitric oxide as an endogenous mutagen for Sendai virus without antiviral activity. J Virol (2004) 0.92
Components involved in virally mediated membrane fusion and permeability changes. Biochem J (1980) 0.91
Sendai virus-induced hemolysis: reduction in heterogeneity of erythrocyte lipid bilayer fluidity. Proc Natl Acad Sci U S A (1977) 0.91
Dissociation of newly synthesized Sendai viral proteins from the cytoplasmic surface of isolated plasma membranes of infected cells. J Virol (1986) 0.91
Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2. J Virol (1985) 0.89
A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus. J Virol (1994) 0.88
Mutations in multiple domains activate paramyxovirus F protein-induced fusion. J Virol (2004) 0.88
Probing the paramyxovirus fusion (F) protein-refolding event from pre- to postfusion by oxidative footprinting. Proc Natl Acad Sci U S A (2014) 0.87
Virion functions of RNA+ temperature-sensitive mutants of Newcastle disease virus. J Virol (1982) 0.86
Conditional dependence of fusion from within and other cell membrane alterations by Newcastle disease virus. J Virol (1974) 0.86
Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response. J Virol (1988) 0.84
Origin of the minor glycoproteins of murine leukemia viruses. J Virol (1978) 0.84
Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin. J Virol (1988) 0.84
Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses. J Virol (1997) 0.83
Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin. J Virol (1990) 0.83
Structure of the primed paramyxovirus fusion protein. Proc Natl Acad Sci U S A (2012) 0.83
Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication. Biochem J (2000) 0.82
Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice. J Virol (2009) 0.82
Newcastle disease virus infection of L cells. J Virol (1974) 0.82
Effect of tunicamycin on cell fusion induced by Mason-Pfizer monkey virus. J Virol (1981) 0.82
The effects of iodine on the biological activities of myxoviruses. J Hyg (Lond) (1980) 0.82
Thermostabilities of virion activities of Newcastle disease virus: evidence that the temperature-sensitive mutants in complementation groups B, BC, and C have altered HN proteins. J Virol (1983) 0.81
Involvement of spectrin in membrane fusion: induction of fusion in human erythrocyte ghosts by proteolytic enzymes and its inhibition by antispectrin antibody. Proc Natl Acad Sci U S A (1979) 0.81
Cell fusion and some subcellular properties of heterokaryons and hybrids. J Cell Biol (1975) 0.81
Immunoelectron microscopic study on interactions of noninfectious sendai virus and murine cells. J Virol (1981) 0.80
Antigenic relationships among Newcastle disease virus mutants obtained from laboratory strains and from recent California isolates. Infect Immun (1974) 0.80
Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem Biophys Res Commun (1967) 32.60
Glycoprotein staining following electrophoresis on acrylamide gels. Anal Biochem (1969) 12.65
Acrylamide-gel electrophorograms by mechanical fractionation: radioactive adenovirus proteins. Science (1966) 9.59
Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology (1972) 4.05
Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol (1973) 3.49
Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A (1970) 2.73
Nucleocapsid protein subunits of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1970) 2.58
The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis. Virology (1969) 2.50
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Proteins and glycoproteins of paramyxoviruses: a comparison of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1971) 2.44
The structural proteins of Newcastle disease virus. Virology (1969) 1.99
Separation of Newcastle disease virus proteins by polyacrylamide gel electrophoresis. Virology (1969) 1.80
Proteins of Newcastle disease virus and of the viral nucleocapsid. J Virol (1969) 1.67
Electrophoretic distribution of the proteins and glycoproteins of influenza virus and Sendai virus. J Virol (1970) 1.67
Trypsin action on the growth of Sendai virus in tissue culture cells. I. Restoration of the infectivity for L cells by direct action of tyrpsin on L cell-borne Sendai virus. J Virol (1971) 1.62
Artificial assembly of envelope particles of HVJ (Sendai virus). I. Assembly of hemolytic and fusion factors from envelopes solubilized by Nonidet P40. Virology (1972) 1.53
HOST INFLUENCE ON THE DENSITY OF NEWCASTLE DISEASE VIRUS (NDV). Virology (1963) 1.52
Restoration of the fusion activity of L cell-borne Sendai virus by trypsin. J Gen Virol (1973) 1.28
Subunits of NDV. Hemagglutinin and neuraminidase subunits of Newcastle disease virus. Virology (1971) 1.23
Trypsin action on the growth of Sendai virus in tissue culture cells. II. Restoration of the hemolytic activity if L cell-borne Sendai virus by trypsin. J Virol (1972) 1.21
Host-controlled variation observed with Sendai virus grown in mouse fibroblast (L) cells. Virology (1961) 1.17
Host-controlled variation in NDV. Virology (1962) 1.13
A host-induced modification of hemagglutinating virus of Japan (HVJ, Sendai virus) in its hemolytic and cytopathic activity. Virology (1962) 1.07
A particular binding of L cell-grown Sendal virus by host L cells. (Growth characteristics of myxoviruses in tissue culture. 5th). Tohoku J Exp Med (1961) 1.06
Polykaryocyte induction by Newcastle disease virus propagated on different hosts. J Gen Virol (1970) 1.03
Characteristics of growth of HVJ in PS cells. Biken J (1962) 1.01
Solubilization of envelopes of HVJ (Sendai virus) with alkali-emasol treatment and reassembly of envelope particles with removal of the detergent. J Virol (1972) 0.99
Isolation of hemagglutinin and neuraminidase subunits of hemagglutinating virus of Japan. J Virol (1970) 0.99
Specific requirement of serine for the growth of Newcastle disease virus. Virology (1969) 0.96
Salmonella typhimurium mutants defective in flagellar filament regrowth and sequence similarity of FliI to F0F1, vacuolar, and archaebacterial ATPase subunits. J Bacteriol (1991) 3.45
Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med (1994) 2.96
Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest (1981) 2.68
Flagellar switch of Salmonella typhimurium: gene sequences and deduced protein sequences. J Bacteriol (1989) 2.55
L-, P-, and M-ring proteins of the flagellar basal body of Salmonella typhimurium: gene sequences and deduced protein sequences. J Bacteriol (1989) 2.43
Regions of Salmonella typhimurium flagellin essential for its polymerization and excretion. J Bacteriol (1987) 2.35
Hook-associated proteins essential for flagellar filament formation in Salmonella typhimurium. J Bacteriol (1984) 2.31
Excretion of unassembled flagellin by Salmonella typhimurium mutants deficient in hook-associated proteins. J Bacteriol (1984) 2.26
Structural genes for flagellar hook-associated proteins in Salmonella typhimurium. J Bacteriol (1985) 2.16
The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum (1983) 2.09
Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene (2006) 2.09
The flaFIX gene product of Salmonella typhimurium is a flagellar basal body component with a signal peptide for export. J Bacteriol (1987) 1.98
Genetic analysis of three additional fla genes in Salmonella typhimurium. J Gen Microbiol (1984) 1.95
The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J Virol (1996) 1.94
Locations of hook-associated proteins in flagellar structures of Salmonella typhimurium. J Bacteriol (1985) 1.86
The sodium-driven polar flagellar motor of marine Vibrio as the mechanosensor that regulates lateral flagellar expression. Mol Microbiol (1996) 1.80
Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome. Proc Natl Acad Sci U S A (1990) 1.74
Signaling by the Escherichia coli aspartate chemoreceptor Tar with a single cytoplasmic domain per dimer. Science (1996) 1.72
Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrata. J Gen Microbiol (1991) 1.71
Cloning and characterization of motY, a gene coding for a component of the sodium-driven flagellar motor in Vibrio alginolyticus. J Bacteriol (1996) 1.68
Export of an N-terminal fragment of Escherichia coli flagellin by a flagellum-specific pathway. Proc Natl Acad Sci U S A (1989) 1.66
Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. J Gen Virol (1997) 1.64
Trypsin action on the growth of Sendai virus in tissue culture cells. I. Restoration of the infectivity for L cells by direct action of tyrpsin on L cell-borne Sendai virus. J Virol (1971) 1.62
Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures. J Gen Virol (1994) 1.61
Isolation of the polar and lateral flagellum-defective mutants in Vibrio alginolyticus and identification of their flagellar driving energy sources. J Bacteriol (1995) 1.60
Identification of flagellar hook and basal body gene products (FlaFV, FlaFVI, FlaFVII and FlaFVIII) in Salmonella typhimurium. J Bacteriol (1987) 1.58
Functional reconstitution of the Na(+)-driven polar flagellar motor component of Vibrio alginolyticus. J Biol Chem (2000) 1.58
Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. Proc Natl Acad Sci U S A (2000) 1.57
Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum (1994) 1.54
Identification of proteins of the outer (L and P) rings of the flagellar basal body of Escherichia coli. J Bacteriol (1987) 1.54
Effect of viscosity on swimming by the lateral and polar flagella of Vibrio alginolyticus. J Bacteriol (1996) 1.53
Variation in the electrophoretic karyotype analysed by the assignment of DNA probes in Candida albicans. J Gen Microbiol (1990) 1.53
Sendai virus. Adv Virus Res (1978) 1.51
Isolation and characterization of a repeated sequence (RPS1) of Candida albicans. J Gen Microbiol (1992) 1.51
Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol Suppl (1986) 1.50
Putative channel components for the fast-rotating sodium-driven flagellar motor of a marine bacterium. J Bacteriol (1997) 1.49
Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes. J Immunol (1982) 1.47
In vitro reconstitution of flagellar filaments onto hooks of filamentless mutants of Salmonella typhimurium by addition of hook-associated proteins. Proc Natl Acad Sci U S A (1986) 1.45
Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis. J Rheumatol (1996) 1.43
Massive pericardial effusion in scleroderma: a review of five cases. Br J Rheumatol (1995) 1.42
Characterization of the flagellar hook length control protein fliK of Salmonella typhimurium and Escherichia coli. J Bacteriol (1996) 1.42
Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies. Clin Immunol Immunopathol (1980) 1.41
On the study of Sendai virus hemolysis. I. Complete Sendai virus lacking in hemolytic activity. Virology (1976) 1.40
Chemotactic adaptation is altered by changes in the carboxy-terminal sequence conserved among the major methyl-accepting chemoreceptors. J Bacteriol (1998) 1.39
Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs. Infect Immun (1983) 1.39
Na(+)-driven flagellar motor of Vibrio. Biochim Biophys Acta (2001) 1.37
An outbreak of type C influenza in a children's home. J Infect Dis (1983) 1.36
Thermosensing properties of mutant aspartate chemoreceptors with methyl-accepting sites replaced singly or multiply by alanine. J Bacteriol (1997) 1.36
Clinical manifestations of tularemia in Japan--analysis of 1,355 cases observed between 1924 and 1987. Infection (1991) 1.35
Localization and stoichiometry of hook-associated proteins within Salmonella typhimurium flagella. J Bacteriol (1987) 1.33
Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. J Gen Virol (1995) 1.32
The polar flagellar motor of Vibrio cholerae is driven by an Na+ motive force. J Bacteriol (1999) 1.30
The AI/RHEUM knowledge-based computer consultant system in rheumatology. Performance in the diagnosis of 59 connective tissue disease patients from Japan. Arthritis Rheum (1988) 1.30
Restoration of the fusion activity of L cell-borne Sendai virus by trypsin. J Gen Virol (1973) 1.28
Na+-driven flagellar motor resistant to phenamil, an amiloride analog, caused by mutations in putative channel components. J Mol Biol (1999) 1.28
Excretion of unassembled hook-associated proteins by Salmonella typhimurium. J Bacteriol (1985) 1.27
Increased induction of apoptosis by a Sendai virus mutant is associated with attenuation of mouse pathogenicity. J Virol (1998) 1.25
Estimation of chromosome number and size by pulsed-field gel electrophoresis (PFGE) in medically important Candida species. J Gen Microbiol (1992) 1.25
Clonal variation of chromosome size derived from the rDNA cluster region in Candida albicans. J Gen Microbiol (1992) 1.24
Formation of flagella lacking outer rings by flaM, flaU, and flaY mutants of Escherichia coli. J Bacteriol (1987) 1.24
Diversity of tandemly repetitive sequences due to short periodic repetitions in the chromosomes of Candida albicans. J Bacteriol (1994) 1.22
In vitro TNP-specific antibody formation by peripheral lymphocytes from patients with systemic lupus erythematosus. Scand J Immunol (1977) 1.21
Trypsin action on the growth of Sendai virus in tissue culture cells. II. Restoration of the hemolytic activity if L cell-borne Sendai virus by trypsin. J Virol (1972) 1.21
Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest (1993) 1.21
Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism (1983) 1.19
Microagglutination test for early and specific serodiagnosis of tularemia. J Clin Microbiol (1990) 1.17
High-speed rotation and speed stability of the sodium-driven flagellar motor in Vibrio alginolyticus. J Mol Biol (1995) 1.16
Multimeric structure of PomA, a component of the Na+-driven polar flagellar motor of vibrio alginolyticus. J Biol Chem (2000) 1.15
Evidence of proteolytic activation of Sendai virus in mouse lung. Arch Virol (1983) 1.14
Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera. Infect Immun (1992) 1.13
Trypsin action on the growth of Sendai virus in tissue culture cells. V. An activating enzyme for Sendai virus in the chorioallantoic fluid of the embryonated chicken egg. Microbiol Immunol (1980) 1.12
Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum (1992) 1.11
Functional interaction between PomA and PomB, the Na(+)-driven flagellar motor components of Vibrio alginolyticus. J Bacteriol (1999) 1.11
Vibrio alginolyticus mutants resistant to phenamil, a specific inhibitor of the sodium-driven flagellar motor. J Mol Biol (1997) 1.10
Immunological reactivity in patients with systemic lupus erythematosus. Humoral antibody and cellular immune responses. Acta Rheumatol Scand (1971) 1.08
The synthesis of polypeptides in influenza C virus-infected cells. Virology (1983) 1.07
Clonal size-variation of rDNA cluster region on chromosome XII of Saccharomyces cerevisiae. J Gen Microbiol (1993) 1.06
Follow-up study of type C influenza outbreak in a children's home. Microbiol Immunol (1987) 1.06
Single amino acid substitution of Sendai virus at the cleavage site of the fusion protein confers trypsin resistance. J Gen Virol (1987) 1.05
Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan. J Clin Microbiol (1997) 1.04
Pharmacokinetic evaluation of traditional Chinese herbal remedies. Lancet (1993) 1.04
Studies of anti-lymphocyte antibody of patients with active SLE. I. Cause of loss of suppressor T-lymphocyte function. Scand J Immunol (1979) 1.04
Properties of the erythrocyte receptors for influenza C virus. Microbiol Immunol (1978) 1.03
Molecular cloning of cDNA encoding Sm autoantigen: derivation of a cDNA for a B polypeptide of the U series of small nuclear ribonucleoprotein particles. Proc Natl Acad Sci U S A (1989) 1.03
Hybrid motor with H(+)- and Na(+)-driven components can rotate Vibrio polar flagella by using sodium ions. J Bacteriol (1999) 1.03
Effect of tunicamycin on the replication of Sendai virus. Virology (1982) 1.03
Transmembrane signalling by the chimeric chemosensory receptors of Escherichia coli Tsr and Tar with heterologous membrane-spanning regions. Mol Microbiol (1994) 1.02
Modulation of the thermosensing profile of the Escherichia coli aspartate receptor tar by covalent modification of its methyl-accepting sites. J Biol Chem (1996) 1.02
Isolation and characterization of subacute sclerosing panencephalitis virus (Yamagata-1 strain) from a brain autopsy. Microbiol Immunol (1982) 1.01
Conversion of a bacterial warm sensor to a cold sensor by methylation of a single residue in the presence of an attractant. Mol Microbiol (1999) 1.01
On the study of Sendai virus hemolysis. II. Morphological study of envelop fusion and hemolysis. Virology (1976) 1.01
Gastric acid stimulating action of cysteamine in the rat. Eur J Pharmacol (1976) 1.00
Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation. Oncogene (2007) 1.00
Age distribution of the antibody to type C influenza virus. Microbiol Immunol (1982) 1.00
Cloning and characterization of motX, a Vibrio alginolyticus sodium-driven flagellar motor gene. J Biochem (2001) 1.00
Subtype analysis of hepatitis C virus in Indonesia on the basis of NS5b region sequences. J Clin Microbiol (1994) 1.00
Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis. Arch Dermatol (1974) 0.99
Coupling ion specificity of chimeras between H(+)- and Na(+)-driven motor proteins, MotB and PomB, in Vibrio polar flagella. EMBO J (2000) 0.99
Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol (1999) 0.98
Antivenin for the treatment of local tissue damage due to envenomation by Southeast Asian snakes. Ineffectiveness in the prevention of local tissue damage in mice after envenomation. Am J Trop Med Hyg (1970) 0.98